Skip to content
MedsAcross

Brand family

Zenpep

United States
Presentations
8
Markets
1

Zenpep is a brand of Pancrelipase amylase, Pancrelipase lipase and Pancrelipase protease marketed by Aimmune Therapeutics, with 8 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Pancrelipase amylase, Pancrelipase lipase and Pancrelipase protease
Brand owner
Aimmune Therapeutics
Registered in
United States
Strengths and forms
105000 units/25000 units/79000 units delayed-release capsule, 14000 units/3000 units/10000 units delayed-release capsule, 168000 units/40000 units/126000 units delayed-release capsule, 24000 units/5000 units/17000 units delayed-release capsule, 252600 units/60000 units/189600 units delayed-release capsule, 42000 units/10000 units/32000 units delayed-release capsule, 63000 units/15000 units/47000 units delayed-release capsule, 84000 units/20000 units/63000 units delayed-release capsule

All presentations

Equivalent brands

Other brands of Pancrelipase amylase, Pancrelipase lipase and Pancrelipase protease.

Brand names and trademarks belong to their owners and are used only to identify products.

Request Zenpep

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.